Biography:
Dr Cherie Ann Kruger (PhD: Biomedical Technology) is an academic researcher and manager at the University of Johannesburg, Complementary Medicine Department. Her research interest lies extensively within alternative complementary medicine drug development delivery systems for the effective treatment of various diseases which exhibit antimicrobial resistance to conventional medications. This year she was awarded her NRF Y2 rating (2023), benchmarking the quality of her research and impact worldwide. Moreover, in 2019 she received the esteemed UJ Vice Chancellor’s Distinguished Award for Most Promising Researcher. Currently she holds a Scopus H-index of 16, with 23 published research articles in SCI(E) journals.Dr Cherie Ann Kruger (PhD: Biomedical Technology) is an academic researcher and manager at the University of Johannesburg, Complementary Medicine Department. Her research interest lies extensively within alternative complementary medicine drug development delivery systems for the effective treatment of various diseases which exhibit antimicrobial resistance to conventional medications. This year she was awarded her NRF Y2 rating (2023), benchmarking the quality of her research and impact worldwide. Moreover, in 2019 she received the esteemed UJ Vice Chancellor’s Distinguished Award for Most Promising Researcher. Currently she holds a Scopus H-index of 16, with 23 published research articles in SCI(E) journals.
Title : The Antibacterial Effect of Cannabis sativa Complementary Medicine Preparations on Clinically Relevant and Pathogenic Strains of Staphylococcus Species in vitro